SGLTR M 1000 (Remogliflozin Etabonate (100mg) + Metformin (1000mg))

Sgltr M 1000mg Tablet is a therapeutic combination aimed at managing blood glucose levels. This medication is indicated for adults diagnosed with type 2 diabetes mellitus and is designed to be used alongside a balanced diet and regular physical activity to enhance glycemic control. It promotes effective insulin utilization, which contributes to lowering blood glucose concentrations. It is essential to follow the prescribed dosage and treatment duration as instructed by your healthcare provider. This medication can be taken either with or without food but should ideally be consumed at the same time each day for optimal effectiveness. In cases where a dose is missed, it should be taken as soon as possible; however, if the next dose is nearing, the missed dose should be skipped to avoid doubling up. Caution is advised, as taking too much can result in hypoglycemia (reduced blood sugar levels). Some individuals may experience low blood sugar if this drug is taken alongside other diabetes medications, alcohol, or if a meal is missed. Regular monitoring of blood sugar levels is important during treatment. Other frequent adverse reactions include nausea, gastrointestinal discomfort, and abdominal pain, but these symptoms are generally transient and will typically resolve independently. If they persist or cause concern, it is important to consult a healthcare provider. Prior to initiation of Sgltr M 1000mg Tablet, inform your physician regarding any pre-existing renal, hepatic, or cardiovascular conditions. Pregnant or breastfeeding individuals should also seek medical advice before use. Kidney function tests may be conducted by your doctor before starting this treatment. It is advisable to limit alcohol consumption while on this medication to reduce the likelihood of adverse effects.